Partial purification, properties and regulation of inosine 5'phosphate dehydrogenase in normal and malignant rat tissues
- PMID: 197916
- PMCID: PMC1164949
- DOI: 10.1042/bj1660001
Partial purification, properties and regulation of inosine 5'phosphate dehydrogenase in normal and malignant rat tissues
Abstract
IMP dehydrogenase (EC 1.2.1.14) was purified 180-fold from rat liver and from the transplantable rat hepatoma 3924A. The enzymes from the two sources were apparently identical; they exhibited hyperbolic saturation kinetics and an ordered, sequential mechanism, and were subject to inhibition by a number of purine nucleotides. Km values for the substrates, IMP and NAD+, were 12 and 24 micrometer respectively. IMP dehydrogenase activity in a spectrum of rat hepatomas was increased, relative to normal liver, by 2.5--13-fold; these increases correlated with tumour growth rate. Activity in two rat kidney tumours was increased 3-fold relative to that in normal renal cortex; control of activity of this enzyme is apparently altered in neoplastic cells. After partial hepatectomy, IMP dehydrogenase activity began to rise 6 h after operation, reaching a peak of 580% of normal activity by 18 h. Activity in neonatal liver, however, was only slightly higher than that in the adult. Organ-distribution studies showed highest enzyme activities in spleen and thymus. In livers of rats starved for 3 days, where all enzymes, except those involved in gluconeogenesis, showed decreased activity IMP dehydrogenase activity was increased; this change was accompanied by a rise in hepatic GTP concentrations. It is concluded that IMP dehydrogenase is a key enzyme in the regulation of GTP production, and thus involved in regulation of nucleic acid biosynthesis. The increased activity of IMP dehydrogenase in liver of starved rats may be related to the requirements for GTP for gluconeogenesis.
Similar articles
-
Behavior of transaldolase (EC 2.2.1.2) and transketolase (EC 2.2.1.1) Activities in normal, neoplastic, differentiating, and regenerating liver.Cancer Res. 1976 Sep;36(9 pt.1):3189-97. Cancer Res. 1976. PMID: 10080
-
Purification of IMP dehydrogenase from rat hepatoma 3924A.Life Sci. 1987 Jun 8;40(23):2277-82. doi: 10.1016/0024-3205(87)90064-6. Life Sci. 1987. PMID: 2884545
-
Adenosine deaminase and adenosine kinase in rat hepatomas and kidney tumours.Br J Cancer. 1978 May;37(5):701-13. doi: 10.1038/bjc.1978.107. Br J Cancer. 1978. PMID: 207296 Free PMC article.
-
Kinetic properties of IMP dehydrogenase purified from rat hepatoma 3924A.Adv Exp Med Biol. 1989;253B:51-5. doi: 10.1007/978-1-4684-5676-9_9. Adv Exp Med Biol. 1989. PMID: 2575351 No abstract available.
-
Purification, characterization, and kinetic analysis of inosine 5'-monophosphate dehydrogenase of Tritrichomonas foetus.Mol Biochem Parasitol. 1987 May;24(1):1-12. doi: 10.1016/0166-6851(87)90110-1. Mol Biochem Parasitol. 1987. PMID: 2886911
Cited by
-
Crystallization and preliminary X-ray analysis of mycophenolic acid-resistant and mycophenolic acid-sensitive forms of IMP dehydrogenase from the human fungal pathogen Cryptococcus.Acta Crystallogr Sect F Struct Biol Cryst Commun. 2010 Sep 1;66(Pt 9):1104-7. doi: 10.1107/S1744309110031659. Epub 2010 Aug 28. Acta Crystallogr Sect F Struct Biol Cryst Commun. 2010. PMID: 20823538 Free PMC article.
-
Inosine 5'-phosphate dehydrogenase activity in normal and leukemic blood cells.Klin Wochenschr. 1979 Oct 15;57(20):1109-15. doi: 10.1007/BF01481491. Klin Wochenschr. 1979. PMID: 292819
-
Inosine-5'-monophosphate dehydrogenase is a rate-determining factor for p53-dependent growth regulation.Mol Biol Cell. 1998 Jan;9(1):15-28. doi: 10.1091/mbc.9.1.15. Mol Biol Cell. 1998. PMID: 9436988 Free PMC article.
-
MYBL2 regulates de novo purine synthesis by transcriptionally activating IMPDH1 in hepatocellular carcinoma cells.BMC Cancer. 2022 Dec 9;22(1):1290. doi: 10.1186/s12885-022-10354-4. BMC Cancer. 2022. PMID: 36494680 Free PMC article.
-
Metabolomic Detection Between Pancreatic Cancer and Liver Metastasis Nude Mouse Models Constructed by Using the PANC1-KAI1/CD82 Cell Line.Technol Cancer Res Treat. 2021 Jan-Dec;20:15330338211045204. doi: 10.1177/15330338211045204. Technol Cancer Res Treat. 2021. PMID: 34605330 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials